“Apremilast As an Off-Label Therapeutic Agent: A Comprehensive Review of Safety and Efficacy Data in the Literature for Combination Therapy and Inflammatory Dermatoses”. 2021. SKIN The Journal of Cutaneous Medicine 5 (3): 203-27. https://doi.org/10.25251/skin.5.3.2.